Although treatment with IgM-enriched immunoglobulin was associated with a significantly lower risk of mortality compared with controls for patients with proven sepsis (p < 0.001), significance was not reached in the analysis of patients with suspected sepsis (p = 0.067). This evidence concerns the gene CD40LG and Sepsis.